Subscribe to RSS - home infusion

home infusion

NHIA: 'Where the best learning happens'

 - 
02/21/2014

ORLANDO, Fla. – Hang on infusion providers. It’s going to be a bumpy ride. Fortunately, the National Home Infusion Association’s (NHIA) annual conference aims to help you thrive, say association execs.

BioScrip sells home health business

 - 
02/03/2014

ELMSFORD, N.Y. – BioScrip plans to sell its home health business, Deaconess HomeCare, to LHC Group for $60 million in cash, the company announced Feb. 3.

Private equity has appetite for home infusion

 - 
01/15/2014

YARMOUTH, Maine – Demand for home infusion companies at both ends of the scale was strong in 2013, say analysts.

Home infusion stakeholders await fallout

 - 
12/20/2013

ALEXANDRIA, Va. – The list of home infusion contract suppliers in the Round 1 re-compete of competitive bidding includes some big names, but stakeholders say about half of the list includes companies without an associated pharmacy.

CVS buys Coram

 - 
11/27/2013

LAKE FOREST, Calif. – CVS Caremark has agreed to acquire Apria’s home infusion business, Coram, for $2.1 billion, the companies announced today.

Pull home infusion from bid program, stakeholders say

 - 
11/22/2013

ALEXANDRIA, Va. – Home infusion stakeholders say they are eyeing possible legislative fixes to address the inclusion of the therapy in competitive bidding.

Language lessons

 - 
11/22/2013

DEERFIELD, Ill. – Working with patients on their own turf to adhere to treatment is always a challenge—even more so when there are language and cultural differences.

Apria building momentum, CEO says

 - 
08/09/2013

LAKE FOREST, Calif. – Apria Healthcare has experienced its “strongest results” in several years, company officials said during an earnings call Aug. 9. 

BioScrip obtains credit facility

 - 
07/31/2013

ELMSFORD, N.Y. – BioScrip has secured a $75 million revolving credit facility, it announced today in a press release. A portion of it will be used toward the purchase of Cincinnati-based CarePoint Partners.

Home infusion market stable, strong

Cost-effectiveness of therapy, steady reimbursement drive buyer interest, say analysts
 - 
07/24/2013

When it comes to home infusion, big deals may be fewer and farther between, but there’s still a lot of runway for buyers and sellers looking to make smaller deals, say industry analysts. 

Pages